Clinical trial
Incretins in Impaired Fasting Glucose
NCT00364377 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00364377 |
|---|---|
| Title | Incretins in Impaired Fasting Glucose |
| Official title | The Role of Incretins in the Pathogenesis of Fasting and Postprandial Glucose Metabolism in People With Impaired Fasting Glucose |
| Lead sponsor | Mayo Clinic, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pre-diabetes |
| Intervention type | Drug, Other |
| Interventions | Sitagliptin, Placebo |
| Enrollment | 22 |
| Start date | Aug 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Aug 15, 2006 |
| Last update posted | Dec 6, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: